wealthy

Download the Wealthy Appto enjoy efficient Trading and Investing!

Download App QR Code
google-playapp-store

Welcome to Wealthy

user
mobile
OR
google-playapp-store
Curated Investing
Curated Investing
Completely Digitalised
Completely Digitalised
Bank Grade Security
Bank Grade Security
Help Centers
Help Centers

Unbeatable brokerage with wealthy broking  

Get Started

Hot Pursuit

15 Mar '25|12:44 PM

Alkem Lab's Bioequivalence Center clears USFDA inspection without observations

The inspection concluded that no Form 483 had been issued.

Alkem Laboratories is engaged in the pharmaceutical business with global operations. The company is engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products.

The company's consolidated net profit declined 1.8% to Rs 625.82 crore in Q3 FY25 as compared with Rs 637.37 crore in Q3 FY24. Net sales rose 1.5% YoY to Rs 3,374.28 crore in Q3 FY25.

Shares of Alkem Laboratories shed 0.97% to end at Rs 4,704.10 on Thursday, 13 March 2025.

Powered by Capital Market - Live News